ATE150304T1 - Tricyclische verbindungen enthaltende salben - Google Patents

Tricyclische verbindungen enthaltende salben

Info

Publication number
ATE150304T1
ATE150304T1 AT91114598T AT91114598T ATE150304T1 AT E150304 T1 ATE150304 T1 AT E150304T1 AT 91114598 T AT91114598 T AT 91114598T AT 91114598 T AT91114598 T AT 91114598T AT E150304 T1 ATE150304 T1 AT E150304T1
Authority
AT
Austria
Prior art keywords
tricyclic compounds
ointments containing
containing tricyclic
ointment
octacos
Prior art date
Application number
AT91114598T
Other languages
English (en)
Inventor
Sotoo Asakura
Yoshio Murakami
Nobuto Kanagawa
Toshiomi Nakate
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16982211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE150304(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE150304T1 publication Critical patent/ATE150304T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT91114598T 1990-09-04 1991-08-30 Tricyclische verbindungen enthaltende salben ATE150304T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23517790 1990-09-04

Publications (1)

Publication Number Publication Date
ATE150304T1 true ATE150304T1 (de) 1997-04-15

Family

ID=16982211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91114598T ATE150304T1 (de) 1990-09-04 1991-08-30 Tricyclische verbindungen enthaltende salben

Country Status (20)

Country Link
US (1) US5385907A (de)
EP (1) EP0474126B1 (de)
JP (1) JP2526752B2 (de)
KR (1) KR100194240B1 (de)
CN (1) CN1069193C (de)
AT (1) ATE150304T1 (de)
AU (1) AU656145B2 (de)
CA (1) CA2050623C (de)
DE (1) DE69125230T2 (de)
DK (1) DK0474126T3 (de)
ES (1) ES2099112T3 (de)
GR (1) GR3022883T3 (de)
HK (1) HK1000006A1 (de)
HU (2) HUT59002A (de)
IE (1) IE913085A1 (de)
PH (1) PH31282A (de)
PT (1) PT98862B (de)
RU (1) RU2079303C1 (de)
SG (1) SG46547A1 (de)
ZA (1) ZA916983B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0669127B1 (de) * 1992-11-18 1999-08-11 Fujisawa Pharmaceutical Co., Ltd. Pharmazeutische zubereitung mit verlängerter wirkung
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
AU735106B2 (en) * 1994-10-26 2001-06-28 Novartis Ag Pharmaceutical compositions
DE19549794B4 (de) * 1994-10-26 2009-07-30 Novartis Ag Pharmazeutische Zusammensetzungen
ES2173978T3 (es) * 1994-10-26 2002-11-01 Novartis Ag Utilizacion de un alcohol graso insaturado.
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
AR004480A1 (es) * 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
AU5340298A (en) * 1996-12-27 1998-07-31 Takeda Chemical Industries Ltd. Stabilized tricyclic compound
TW450810B (en) * 1997-02-20 2001-08-21 Fujisawa Pharmaceutical Co Macrolides antibiotic pharmaceutical composition for preventing and treating skin diseases
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
RU2149635C1 (ru) * 1998-02-27 2000-05-27 Пермская государственная медицинская академия Способ лечения аллергических дерматитов
WO1999055332A1 (en) * 1998-04-27 1999-11-04 Fujisawa Pharmaceutical Co., Ltd. Medicinal compositions
GB9817064D0 (en) * 1998-08-05 1998-10-07 Fujisawa Pharmaceutical Co New use
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
AUPR529701A0 (en) * 2001-05-28 2001-06-21 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
RU2183113C1 (ru) * 2001-06-28 2002-06-10 Новицкий Юрий Алексеевич Средство-гидросульфат графита и способ лечения больных с доброкачественными и злокачественными опухолями кожи (варианты)
KR20040019034A (ko) * 2001-07-06 2004-03-04 수캄포 아게 인터루킨 2 억제제 및 항미생물제를 포함하는 국소 투여용조성물
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
JP2005536516A (ja) * 2002-07-23 2005-12-02 ノバルティス アクチエンゲゼルシャフト 薬剤、軟膏基剤および可溶化剤／分散剤を含む、眼科用軟膏組成物
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
RU2231359C1 (ru) * 2002-12-11 2004-06-27 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М.Сеченова Способ лечения язвенных форм ангиитов кожи
ZA200702216B (en) * 2004-08-18 2008-11-26 Ace Aps Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
CA2526419C (en) * 2005-01-04 2012-09-25 Texas United Chemical Company, Llc Compounded hydrocarbon oil and oil base drilling fluids prepared therefrom
EP1852120A1 (de) * 2005-02-14 2007-11-07 Taisho Pharmaceutical Co., Ltd Salbe
JPWO2006098353A1 (ja) * 2005-03-15 2008-08-28 協和醗酵工業株式会社 外用剤
JP4767968B2 (ja) * 2005-10-05 2011-09-07 田辺三菱製薬株式会社 皮膚炎治療剤
EP1992622B1 (de) 2006-02-21 2011-07-27 Eisai R&D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminochinazolinderivat
EP2123641A4 (de) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd Kristall, amorphe form und salt von methyl n-[3-(6,7-dimethoxy- 2-methylaminochinazolin-4-yl)phenyl]terephthalamsäure
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
AU2008290001B2 (en) 2007-08-17 2012-08-09 Eisai R & D Management Co., Ltd. Novel preparation for external use
JP5135441B2 (ja) * 2008-10-08 2013-02-06 高田製薬株式会社 タクロリムス外用剤
JP2010132607A (ja) * 2008-12-05 2010-06-17 Taisho Pharm Ind Ltd アトピー性皮膚炎治療用軟膏剤
JP2010202546A (ja) * 2009-03-02 2010-09-16 Taisho Pharm Ind Ltd アトピー性皮膚炎の治療用軟膏製剤
AU2012211809A1 (en) * 2011-01-31 2013-09-05 Osaka University Externally-used drug for treating skin disorder and method for producing same
CN102885761B (zh) * 2012-09-24 2015-08-05 浙江万晟药业有限公司 一种制备他克莫司软膏的方法
RU2538680C2 (ru) * 2013-03-12 2015-01-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения атопического дерматита и способ ее получения
RU2553600C2 (ru) * 2013-05-16 2015-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения заболеваний кожи
CN104127369A (zh) * 2014-07-02 2014-11-05 人福医药集团股份公司 他克莫司软膏及其制备方法
EP3246036B1 (de) 2014-10-28 2021-10-13 Koushi Yamaguchi Mittel zur verbesserung schwangerschaftsinduzierten bluthochdruck
CN106309353A (zh) * 2015-06-19 2017-01-11 江苏吉贝尔药业股份有限公司 一种治疗银屑病的软膏剂及其制备方法
CN109069418A (zh) 2016-04-04 2018-12-21 药品配送方案有限公司 包含他克莫司的局部组合物
CN105769752B (zh) * 2016-04-08 2018-12-11 湖北人福成田药业有限公司 制备他克莫司软膏的方法及他克莫司软膏
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
WO2020032252A1 (ja) 2018-08-10 2020-02-13 晃史 山口 母体と胎児との関係における液性免疫関連疾患の治療薬
WO2020117134A1 (en) 2018-12-04 2020-06-11 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Stable tacrolimus ointment formulation for topical treatment of skin conditions
AU2019401108A1 (en) 2018-12-18 2021-07-01 Koushi Yamaguchi Agent for improving infertility, recurrent miscarriage, and state of pregnancy
CN112439071B (zh) * 2019-09-04 2022-05-20 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用
EP4114357B1 (de) * 2020-03-02 2025-10-01 Shanghai Aucta Pharmaceuticals Co., Ltd. Topische formulierungen mit mtor-hemmern
CN112022798B (zh) * 2020-08-11 2022-04-29 四川大学华西医院 一种速效他克莫司软膏、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175235B1 (da) * 1987-11-09 2004-07-19 Novartis Ag Ny anvendelse af azatricycloderivater og farmaceutiske præparater med indhold deraf
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles

Also Published As

Publication number Publication date
PH31282A (en) 1998-07-06
CN1059468A (zh) 1992-03-18
DK0474126T3 (de) 1997-04-07
AU8351591A (en) 1992-03-12
DE69125230T2 (de) 1997-07-10
JP2526752B2 (ja) 1996-08-21
CN1069193C (zh) 2001-08-08
IE913085A1 (en) 1992-03-11
SG46547A1 (en) 1998-02-20
CA2050623A1 (en) 1992-03-05
PT98862A (pt) 1992-08-31
RU2079303C1 (ru) 1997-05-20
ZA916983B (en) 1992-05-27
ES2099112T3 (es) 1997-05-16
KR920005987A (ko) 1992-04-27
EP0474126B1 (de) 1997-03-19
HUT59002A (en) 1992-04-28
CA2050623C (en) 2002-02-05
HU211470A9 (en) 1995-11-28
KR100194240B1 (ko) 1999-06-15
EP0474126A1 (de) 1992-03-11
PT98862B (pt) 1999-02-26
JPH0517481A (ja) 1993-01-26
GR3022883T3 (en) 1997-06-30
US5385907A (en) 1995-01-31
HK1000006A1 (en) 1997-10-03
DE69125230D1 (de) 1997-04-24
AU656145B2 (en) 1995-01-27

Similar Documents

Publication Publication Date Title
ATE150304T1 (de) Tricyclische verbindungen enthaltende salben
ATE112486T1 (de) Trizyklische verbindungen enthaltende suspensionen.
DE3777223D1 (de) Feste dispersion der substanz fr-900506.
ES2134860T3 (es) Preparacion farmaceutica de accion prolongada.
DK0406791T3 (da) Vandigt flydende præparat til ekstern anvendelse
DK0428169T3 (da) Vandige flydende formuleringer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time